Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 842-851

  Beere, Helen M ^a   Chresta, Christine M ^a   Hickman, John A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; CAMPTOTHECIN; DNA FRAGMENT; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GYRASE INHIBITOR; N METHYLFORMAMIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CHROMATIN; CONTROLLED STUDY; DNA CLEAVAGE; DNA STRAND BREAKAGE; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; FORMAMIDES; HL-60 CELLS; HUMANS; PIPERAZINES;

EID: 0029926662     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Arenas, M. J., R. G. Morris, and A. H. Wyllie. Apoptosis: the role of the endonuclease. Am. J. Pathol. 138:593-608 (1990).
2. Ucker, D. S., P. S. Obermiller, W. Eckhart, J. Apgar, N. Berger, and J. Meyers. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell. Biol. 12:3060-3069 (1992).
3. Oberhammer, P., J. W. Wilson, C. Dive, I. D. Morris, J. A. Hickman, A. E. Wakeling, R. P. Walker, and M. Sikorska. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kbp fragments before or in the absence of internucleosomal fragmentation. EMBO J. 12:3679-3684 (1993).
4. Oberhammer, F., G. Fritsch, M. Schmied, M. Pavelka, D. Printz, T. Purchio, H. Lassmann, and R. Schulte-Herman. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci. 104:317-326 (1993).
5. Beere, H. M., C. M Chresta, A. Alejo-Herberg, A Skladanowski, C. Dive, A. Kragh-Larsen, and J. A. Hickman. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol. Pharmacol. 47:986-996 (1995).
6. Brown, D. G., X. M. Sun, and G. M. Cohen. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments before internucleosomal fragmentation. J Biol Chem. 268:3037-3039 (1993).
7. Sun, X. M , R. Snowden, D. Dinsdale, M. Ormerod, and G. M. Cohen. Changes m nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem. Pharmacol. 2:187-195 (1993).
8. Cohen, G. M, X. M. Sun, R. T. Snowden, D. Dinsdale, and D. N. Skilleter. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:331-334 (1992).
9. Walker, P. R , C. Smith, T. Youdale, J. Leblanc, J. F. Whitfield, and M. Sikorska. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51:1078-1085 (1991).
10. Roy, C., D. L. Brown, J. E. Little, B. K. Valentine, P. R. Walker, M. Sikorska, J. Leblanc, and N. Chaly. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated murine lymphocytes. Exp. Cell. Res. 200:416-424 (1992).
11. Wang, J. C Recent studies of DNA topoisomerases. Biochem. Biophys. Acta 909:1-9 (1987).
12. Berrios, M., N. Osheroff, and P. A. Fisher. In situ localization of DNA topoisomerase II, a major polypeptide component of the drosophila nuclear matrix fraction. Proc. Natl. Acad. Sci. USA 82:4142-4146 (1985).
13. Earnshaw, W. C., and M. S. Heck. Localization of topoisomerase II in mitotic chromosomes. J. Cell Biol. 100:1716-1725 (1985).
14. Earnshaw, W. C., B. Halligan, C. A. Cooke, M. S. Heck, and L. F. Liu. Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell Biol. 100:1706-1715 (1986).
15. Adaehi, Y., E. Kas, and U. K. Laemmli. Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions. EMBO J. 8:3997-4006 (1990).
16. Cockerill, P. N., and W. T. Garrard. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer region containing topoisomerase II sites. Cell 44:273-282 (1986).
17. Gasser, S. M., and U. K. Laemmli. The organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. EMBO J. 5:511-518 (1986).
18. Filipski, J., J. Leblanc, T. Youdale, M. Sikorska, and P. R. Walker. Periodicity of DNA folding in higher order chromatin structures. EMBO J. 9:1319-1327 (1990).
19. Chen, G. L., L. Yang, T. C. Rowe, B. D. Halligan, K M. Tewey, and L. F. Liu. Nonintercalative antitumour drugs interfere with the breakage-reunion of topoisomerase II. J. Biol. Chem. 259:13560-13566 (1984).
20. Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Annu Rev. Biochem. 58:351-375 (1989).
21. Herman, E. H., D. T. Witiak, K. Hellmann, and V. S. Waravdeker. Biological properties of ICRF-159 and other related bis(dioxopiperazine) derivatives. Adv. Pharmacol. Chemother. 19:249-290 (1982).
22. Tanabe, K., Y. Ikegami, R. Ishida, and T. Andoh. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. Cancer Res. 51:4903-4908 (1991).
23. Sehested, M., P. Buhl, B. S. Sorenson, B. Holm, E. Friche, and E. J. F. Demant. Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase H directed drugs daunorubicin and etoposide (VP-16). Biochem. Pharmacol. 46:389-393 (1993).
24. Beere, H. M., J. A. Hickman, R. I. Morimoto, R. Parmar, R. Newbould., and C. M. Waters. Changes in HSC70 and C-myc in HL-60 cells engaging differentiation or apoptosis. Mol. Cell. Diff. 1:323-343 (1993).
25. Collins, S. J., R. C. Gallo, and R. E. Gallagher. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (Lond.) 270:347-349 (1977).
26. Chung, T. D., F. H. Drake, K. B. Tan, S. R. Per, S. T. Crooke, and C. K. Mirabelli. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc. Natl. Acad. Sci. USA 86:9431-9435.
27. Jenkins, J. R., P. Ayton, T. Jones, S. L. Davies, D. L. Simmons, A. L. Harris, D. Sheer, and I. D. Hickson. Isolation of cDNA clones encoding the beta-isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20:5587-5592 (1992).
28. Kohn, K. W., L. C. Ericson, R. Ewig, and C. A. Friedman. Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry 15:4629-4637 (1976).
29. Dive, C., C. D. Gregory, D. J. Phipps, D. L. Evans, A. E. Milner, and A. H. Wyllie. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acte 1133:275-285 (1991).
30. Earnshaw, W. C. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7:337-343 (1995).
31. Ishida, R., T. Miki, T. Narita, R. Yui, M. Sato, K. R. Utsumi, K. Tanabe, and T. Andoh. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res. 51:4909-4916 (1991).
32. Kaufmann, S. H., S. Y. Desnoyers, Y. Ottaviano, N. E. Davidson, and G. Poirier. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976-3985 (1993).
33. Schroter, M., M. Peitsch, P. Gallant, E. A. Nigg, and J. Tschopp. Activation of cdc2 precedes lamin breakdown during apoptosis allowing DNase I to enter the nucleus and leading to DNA breakdown, in Molecular Basis of Immunology. European Network of Immunology Institutes (ENII), Les Embiez, France, (1994).
34. Peitsch, M. C., B. Polzar, H. Stephan, T. Crompton, H. R. MacDonald, H. G. Mannherz, and J. Tschopp. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 12:371-377 (1993).
35. Fearnhead, H. O., J. A. Rivett, D. Dinsdale, and G. M. Cohen. A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli. FEBS Lett. 357:242-246 (1995).
36. 0 cells and is prevented by inhibitors of proteases. Oncol. Res. 4:29-35 (1992).
37. Weaver, V. M., B. Lach P. R. Walker, and M. Sikorska. Role of proteolysis in apoptosis: involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. Biochem. Cell. Biol. 71:488-500 (1993).